EPA Comment Period for SpecGx LLC - Mallinckrodt Pharmaceuticals

-

The North Carolina Division of Air Quality (DAQ) hereby gives notice of its intent to issue an Air Quality Permit to:

SpecGx LLC - Mallinckrodt Pharmaceuticals
8801 Capital Boulevard
Raleigh, NC 27616
Wake County
Application ID: 9200349.24A, Permit No.: 01479T64

This facility applied for an Air Quality Title V Operation Permit which meets the requirements specified in 15A North Carolina Administrative Code 2Q.0500.

EPA comment period begins on August 15, 2024 and will run through September 29, 2024.

Public Notice
Draft Permit
Draft Permit Review

Engineer: Connie Horne

Submit Comments